CD63 and cancer: As presented in Fig. 7c, four bio-orthogonal click probes modified with trans-cyclooctene (TCO) were designed to enable the specific targeting of three cancer proteins (EGFR, EpCAM and MUC1) and one generic EV marker (CD63).